Enrollment continues at a steady pace of 20-30 subjects per month. More than 200,000 biological samples have been processed, quality-controlled, bar-coded and stored. The table below shows the number of subjects with biological and clinical data collected by disease status as of 10/31/2015 (Modest access fees apply).
|
|
Number of Subjects with |
|||||
|
E |
12-mo |
24-Mo |
36-mo |
48-mo |
60-mo |
|
|
Alzheimer’s Disease (AD) |
150 |
93 |
63 |
20 |
12 |
|
|
Mild Cognitive Impairment (MCI) |
234 |
137 |
106 |
47 |
35 |
6 |
|
Memory Impaired, Not MCI |
211 |
142 |
150 |
131 |
68 |
22 |
|
Dementias other than AD |
116 |
56 |
29 |
13 |
7 |
5 |
|
Parkinson’s disease (PD) |
718 |
543 |
515 |
3 |
3 |
116 |
|
Healthy Controls |
864 |
575 |
492 |
268 |
84 |
37 |
|
Other Neurodegenerative diseases |
101 |
37 |
37 |
3 |
||
|
TOTAL |
2,394 |
1,583 |
1,392 |
482 |
209 |
189 |